• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃源性腹膜癌:基于人群的发病率、生存率和危险因素研究。

Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.

机构信息

Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Eindhoven Cancer Registry, Comprehensive Cancer Centre South (IKZ), Eindhoven, The Netherlands.

出版信息

Int J Cancer. 2014 Feb 1;134(3):622-8. doi: 10.1002/ijc.28373. Epub 2013 Aug 5.

DOI:10.1002/ijc.28373
PMID:23832847
Abstract

Peritoneal carcinomatosis (PC) is an important cause of morbidity and mortality among patients with gastric cancer. The aim of the current study was to provide reliable population-based data on the incidence, risk factors and prognosis of PC of gastric origin. All patients diagnosed with gastric cancer in the area of the Eindhoven Cancer Registry between 1995 and 2011 were included. Incidence and survival were computed and risk factors for peritoneal carcinomatosis were determined using multivariate logistic regression analysis. In total, 5,220 patients were diagnosed with gastric cancer, of whom 2,029 (39%) presented with metastatic disease. PC was present in 706 patients (14%) of whom 491 patients (9%) had PC as the only metastatic site. Younger age (<60 years), female gender, advanced T- and N-stage, primary tumor of signet ring cells or linitis plastica and primary tumors covering multiple anatomical locations of the stomach were all associated with a higher odds ratios of developing PC. Median survival of patients without metastases was 14 months, but only 4 months for patients with PC. PC is a frequent condition in patients presenting with gastric cancer, especially in younger patients with advanced tumor stages. Given the detrimental influence of PC on survival, efforts should be undertaken to further explore the promising results that were obtained in preventing or treating this condition with multimodality strategies.

摘要

腹膜癌转移(PC)是胃癌患者发病率和死亡率的重要原因。本研究旨在提供可靠的基于人群的胃来源 PC 的发病率、危险因素和预后数据。所有在 1995 年至 2011 年间被 Eindhoven 癌症登记处诊断为胃癌的患者均被纳入研究。计算发病率和生存率,并使用多变量逻辑回归分析确定腹膜癌转移的危险因素。共诊断出 5220 例胃癌患者,其中 2029 例(39%)为转移性疾病。706 例患者存在腹膜癌转移,其中 491 例(9%)为唯一的转移部位。年龄较轻(<60 岁)、女性、较晚期的 T 和 N 分期、原发肿瘤为印戒细胞癌或皮革胃以及原发肿瘤覆盖胃的多个解剖部位均与更高的发生 PC 的比值比相关。无转移患者的中位生存时间为 14 个月,但 PC 患者仅为 4 个月。PC 是胃癌患者中常见的情况,尤其是在较年轻、肿瘤分期较晚的患者中。鉴于 PC 对生存的不利影响,应努力进一步探索在预防或治疗这种疾病方面采用多模式策略所获得的有希望的结果。

相似文献

1
Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.胃源性腹膜癌:基于人群的发病率、生存率和危险因素研究。
Int J Cancer. 2014 Feb 1;134(3):622-8. doi: 10.1002/ijc.28373. Epub 2013 Aug 5.
2
Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.结直肠癌根治性治疗后发生的异时性腹膜癌转移
Eur J Surg Oncol. 2014 Aug;40(8):963-9. doi: 10.1016/j.ejso.2013.10.001. Epub 2013 Oct 16.
3
Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study.胰腺源性腹膜癌的发病率、预后和可能的治疗策略:一项基于人群的研究。
Pancreas. 2013 Jan;42(1):72-5. doi: 10.1097/MPA.0b013e31825abf8c.
4
Peritoneal carcinomatosis in gastric cancer: Are Hispanics at higher risk?胃癌腹膜转移:西班牙裔人群风险更高吗?
J Surg Oncol. 2020 Dec;122(8):1624-1629. doi: 10.1002/jso.26210. Epub 2020 Sep 9.
5
Gastric Cancer Peritoneal Carcinomatosis Risk Score.胃癌腹膜转移危险评分
Ann Surg Oncol. 2020 Jan;27(1):240-247. doi: 10.1245/s10434-019-07624-0. Epub 2019 Jul 25.
6
Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.基于人群的不明来源腹膜转移患者的发病率、治疗和生存情况。
Eur J Cancer. 2014 Jan;50(1):50-6. doi: 10.1016/j.ejca.2013.08.009. Epub 2013 Sep 3.
7
Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.结直肠癌同时合并腹膜转移和肝转移患者的发病率、预后和治疗选择。
Dis Colon Rectum. 2013 Dec;56(12):1373-80. doi: 10.1097/DCR.0b013e3182a62d9d.
8
Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.预测结直肠来源的同时性腹膜癌转移的因素和生存率:一项基于人群的研究。
Int J Cancer. 2011 Jun 1;128(11):2717-25. doi: 10.1002/ijc.25596. Epub 2010 Oct 13.
9
Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients.胃源性异时性腹膜癌转移的发病率、病程及独立危险因素——来自1108例患者前瞻性收集数据库的纵向经验
BMC Cancer. 2015 Feb 19;15:73. doi: 10.1186/s12885-015-1081-8.
10
Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.胃癌腹膜同步转移:一个全国性荷兰队列的发病率、治疗和生存情况。
Gastric Cancer. 2021 Jul;24(4):800-809. doi: 10.1007/s10120-021-01160-1. Epub 2021 Jan 25.

引用本文的文献

1
Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort study.免疫检查点抑制剂联合化疗用于IV期胃癌转化治疗的多中心回顾性队列研究
Cancer Immunol Immunother. 2025 Sep 11;74(10):302. doi: 10.1007/s00262-025-04161-6.
2
Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer.影响胃肠道癌围手术期热灌注腹腔化疗与腹腔化疗血液学毒性及不良反应的因素。
Open Med (Wars). 2025 Aug 29;20(1):20251260. doi: 10.1515/med-2025-1260. eCollection 2025.
3
Enhanced recovery after surgery protocols in gastrectomy with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer.
胃癌行胃切除术、细胞减灭术及腹腔热灌注化疗后的术后加速康复方案
World J Clin Oncol. 2025 Aug 24;16(8):107533. doi: 10.5306/wjco.v16.i8.107533.
4
Involvement of Hormone Receptors, Membrane Receptors and Signaling Pathways in European Gastric Cancers Regarding Subtypes and Epigenetic Alterations: A Pilot Study.激素受体、膜受体及信号通路在欧洲胃癌中的作用与亚型及表观遗传改变的关系:一项初步研究
Biomedicines. 2025 Jul 24;13(8):1815. doi: 10.3390/biomedicines13081815.
5
Neoantigen mRNA vaccines induce progenitor-exhausted T cells that support anti-PD-1 therapy in gastric cancer with peritoneal metastasis.新抗原mRNA疫苗可诱导祖细胞耗竭的T细胞,这些细胞可支持对伴有腹膜转移的胃癌进行抗PD-1治疗。
Gastric Cancer. 2025 Jul 31. doi: 10.1007/s10120-025-01640-8.
6
Evaluation of Exosome-Based Delivery of Tumor-Suppressive microRNAs for Novel Therapy in Peritoneal Dissemination of Gastric Cancer: Evidence from Experimental Animal Models.基于外泌体递送肿瘤抑制性微小RNA用于胃癌腹膜播散新疗法的评估:来自实验动物模型的证据
Ann Surg Oncol. 2025 Jul 25. doi: 10.1245/s10434-025-17837-1.
7
Galectins as Master Regulators of Gastric Cancer Progression.半乳糖凝集素作为胃癌进展的主要调节因子
Cells. 2025 Jul 16;14(14):1090. doi: 10.3390/cells14141090.
8
Outcomes of Conversion Surgery vs Conventional Systemic Therapy in Stage IV Gastric Cancer: A Systematic Review and Meta-Analysis.IV期胃癌中转流手术与传统全身治疗的疗效:一项系统评价与Meta分析
J Gastrointest Cancer. 2025 Jul 22;56(1):161. doi: 10.1007/s12029-025-01265-1.
9
Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines.美国镭学会关于不同肿瘤起源的腹膜癌病管理的合理使用标准:系统评价与指南执行摘要
Cancer Med. 2025 Jul;14(14):e71043. doi: 10.1002/cam4.71043.
10
POSTN is exclusively activated in cancer-associated fibroblasts and leads to unfavorable prognosis of patients with gastric cancer.POSTN仅在癌症相关成纤维细胞中被激活,并导致胃癌患者预后不良。
Mol Clin Oncol. 2025 Jul 8;23(3):82. doi: 10.3892/mco.2025.2877. eCollection 2025 Sep.